"Levonorgestrel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
MeSH Number(s)
D04.808.668.651.693.762.450
Concept/Terms
Levonorgestrel- Levonorgestrel
- l-Norgestrel
- l Norgestrel
- D-Norgestrel
- D Norgestrel
Cerazet- Cerazet
- Alcala Brand of Levonorgestrel
- Levonorgestrel Alcala Brand
duofem- duofem
- Hexal Brand of Levonorgestrel
- Levonorgestrel Hexal Brand
Microlut- Microlut
- Schering Brand 2 of Levonorgestrel
Vikela- Vikela
- HRA Brand 2 of Levonorgestrel
Norgeston- Norgeston
- Schering Brand 3 of Levonorgestrel
NorLevo- NorLevo
- HRA Brand 1 of Levonorgestrel
Norplant- Norplant
- Wyeth Brand of Levonorgestrel
- Levonorgestrel Wyeth Brand
- Norplant-2
- Norplant 2
- Norplant2
- Aventis Pharma Brand of Levonorgestrel
- Microval
Plan B- Plan B
- Women's Capital Brand of Levonorgestrel
- Paladin Brand of Levonorgestrel
- Levonorgestrel Paladin Brand
Mirena- Mirena
- Schering Brand 1 of Levonorgestrel
- Berlex Brand of Levonorgestrel
- Levonorgestrel Berlex Brand
Below are MeSH descriptors whose meaning is more general than "Levonorgestrel".
Below are MeSH descriptors whose meaning is more specific than "Levonorgestrel".
This graph shows the total number of publications written about "Levonorgestrel" by people in Harvard Catalyst Profiles by year, and whether "Levonorgestrel" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1997 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2006 | 0 | 2 | 2 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2011 | 2 | 1 | 3 |
2012 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 1 | 2 |
2017 | 3 | 0 | 3 |
2018 | 2 | 1 | 3 |
2019 | 2 | 4 | 6 |
2020 | 1 | 2 | 3 |
2021 | 1 | 5 | 6 |
2022 | 2 | 1 | 3 |
2023 | 0 | 2 | 2 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Levonorgestrel" by people in Profiles.
-
Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. BMC Womens Health. 2024 Mar 08; 24(1):167.
-
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis. Pharmacogenet Genomics. 2023 08 01; 33(6):126-135.
-
Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia. Obstet Gynecol. 2023 05 01; 141(5):979-987.
-
Extending the use of levonorgestrel 52 mg intrauterine devices to 8 years. Am J Obstet Gynecol. 2023 07; 229(1):85.
-
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens. Contraception. 2023 05; 121:109951.
-
Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception. Contraception. 2023 02; 118:109893.
-
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study. PLoS One. 2022; 17(10):e0275794.
-
Delayed pregnancy detection and return to fertility with extended levonorgestrel-containing oral contraceptives: A real world setting cohort study. Pharmacoepidemiol Drug Saf. 2023 01; 32(1):78-83.
-
Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy. Obstet Gynecol. 2022 05 01; 139(5):764-770.
-
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study. Am J Obstet Gynecol. 2022 06; 226(6):821.e1-821.e26.